
25 Aug 2017
Kate: I’m making a difference
Kate’s mother died of acute myloid leukaemia at the age of 34, leaving behind four young children. When Kate reached the same age, she took up running and began to raise money for our cause
My mum died after a short battle with acute myeloid leukaemia. She was 34 and left four children behind – I was eight years old.
I started running nearly three years ago, the year I turned 34. I started with 10k a month for a year, building up to half marathons last year.
I’ve always watched the London Marathon in awe, thinking I would love to do it but never thought it possible. I chose to run it for Leukaemia UK because I wanted to find a leukaemia charity that was relatively local, so that by raising money I would make a difference.
Kate completed the Great North Run and the Great South Run for Leukaemia UK in 2016, then the London Marathon and the Royal Parks Half Marathon in 2017. She raised more than £3,000 for Leukaemia UK – what an inspiration!
We are delighted that Kate has chosen to support us in memory of her mother and are so impressed with her dedication and determination. Thank you!
Read further inspiring fundraising stories, including Esther’s half marathon journey.
Read more stories from our community.
Related posts
3 July 2025
Together we are changing lives – Here’s how your support is making it happen
At this point in our advocacy journey, we wanted to share an update to you, our supporters, on everything we’ve achieved so far and what’s next as we continue to…
16 November 2022
Cost of Living with Leukaemia Fund launches
Leukaemia Care and Leukaemia UK have launched a new financial support service, the Cost of Living with Leukaemia Fund, in response to the cost of living crisis in the UK….
3 February 2022
New analysis reveals the stark disparities in cancer rates between ethnic groups
The Cancer Research UK study demonstrates the importance of understanding the differences and inequalities in cancer and to highlight where improvements in survival, treatment and care can be made.
21 May 2020
A new clinical trial announced
A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.